Guardant Health shares are trading at $149.22, above the average analyst 12-month target price of $145.50. The note is mainly a market-sentiment/valuation update rather than a fundamental catalyst, though it may prompt analysts to reassess ratings or targets. The article implies the stock has run ahead of consensus expectations, but provides no new operating data.
Guardant Health shares are trading at $149.22, above the average analyst 12-month target price of $145.50. The note is mainly a market-sentiment/valuation update rather than a fundamental catalyst, though it may prompt analysts to reassess ratings or targets. The article implies the stock has run ahead of consensus expectations, but provides no new operating data.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.12
Ticker Sentiment
